Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Return on Invested Capital (2020 - 2025)

Collegium Pharmaceutical has reported Return on Invested Capital over the past 6 years, most recently at 0.37% for Q4 2025.

  • Quarterly results put Return on Invested Capital at 0.37% for Q4 2025, down 6.0% from a year ago — trailing twelve months through Dec 2025 was 0.37% (down 6.0% YoY), and the annual figure for FY2025 was 0.42%, up 5.0%.
  • Return on Invested Capital for Q4 2025 was 0.37% at Collegium Pharmaceutical, up from 0.36% in the prior quarter.
  • Over the last five years, Return on Invested Capital for COLL hit a ceiling of 0.47% in Q2 2021 and a floor of 1.08% in Q4 2021.
  • Median Return on Invested Capital over the past 5 years was 0.3% (2023), compared with a mean of 0.19%.
  • Biggest five-year swings in Return on Invested Capital: tumbled -124bps in 2021 and later skyrocketed 113bps in 2022.
  • Collegium Pharmaceutical's Return on Invested Capital stood at 1.08% in 2021, then surged by 105bps to 0.05% in 2022, then surged by 451bps to 0.29% in 2023, then soared by 50bps to 0.43% in 2024, then dropped by -14bps to 0.37% in 2025.
  • The last three reported values for Return on Invested Capital were 0.37% (Q4 2025), 0.36% (Q3 2025), and 0.3% (Q2 2025) per Business Quant data.